The increased serum concentration of beta-2 microglobulin (B2M) is used as a clinical marker for diabetes mellitus [54], and high-mobility group protein B2 (HMGB2) is used as a diagnostic marker for both obese and diabetic patients [55]. The gene discussed is B2M; the disease is diabetes mellitus.